Find Federal Grants
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · PAS-19-317
PEFO Fence Support Project FY19
National Park Service · P19AS00394
National Institutes of Health · RFA-CA-19-057
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · PAS-19-316
Center for Medicare and Medicaid Services · CMS-2D2-20-001
National Institutes of Health · PAR-19-314
National Institutes of Health · RFA-AA-20-002
National Institutes of Health · RFA-AA-20-001
Health Resources and Services Administration · HRSA-20-047
Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-20-015
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-20-023
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
National Institutes of Health · PAR-19-313
National Institutes of Health · PAR-19-311
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-20-007
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-DA-20-006
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
National Institutes of Health · RFA-RM-19-011
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-19-315
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
National Institutes of Health · PAR-19-312
Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-20-004
Nigeria USAID-Abuja · 72062019RFA00007